Intellectus Partners LLC Acquires 46,872 Shares of Enovix Co. (NASDAQ:ENVX)

Intellectus Partners LLC lifted its holdings in Enovix Co. (NASDAQ:ENVX - Free Report) by 84.5% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 102,322 shares of the company's stock after buying an additional 46,872 shares during the quarter. Intellectus Partners LLC owned about 0.05% of Enovix worth $751,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in the business. Thurston Springer Miller Herd & Titak Inc. raised its stake in shares of Enovix by 11.5% in the first quarter. Thurston Springer Miller Herd & Titak Inc. now owns 53,096 shares of the company's stock worth $390,000 after acquiring an additional 5,471 shares during the last quarter. Channel Wealth LLC increased its holdings in shares of Enovix by 19.9% in the first quarter. Channel Wealth LLC now owns 187,612 shares of the company's stock valued at $1,377,000 after purchasing an additional 31,177 shares in the last quarter. Harbor Investment Advisory LLC raised its position in Enovix by 6.7% in the 1st quarter. Harbor Investment Advisory LLC now owns 30,984 shares of the company's stock worth $227,000 after purchasing an additional 1,949 shares during the last quarter. Strong Tower Advisory Services raised its position in Enovix by 93.1% in the 1st quarter. Strong Tower Advisory Services now owns 144,045 shares of the company's stock worth $1,057,000 after purchasing an additional 69,435 shares during the last quarter. Finally, Rhumbline Advisers lifted its holdings in Enovix by 7.1% during the 1st quarter. Rhumbline Advisers now owns 234,685 shares of the company's stock worth $1,723,000 after buying an additional 15,615 shares in the last quarter. 50.92% of the stock is owned by institutional investors.

Enovix Stock Performance

Shares of ENVX stock opened at $8.31 on Friday. The stock has a market cap of $1.60 billion, a PE ratio of -5.73 and a beta of 2.00. The stock has a 50-day moving average of $6.95 and a 200-day moving average of $8.95. The company has a debt-to-equity ratio of 0.99, a current ratio of 3.77 and a quick ratio of 3.61. Enovix Co. has a one year low of $5.27 and a one year high of $18.68.

Analyst Ratings Changes

ENVX has been the subject of several research reports. TD Securities lowered their target price on Enovix from $10.00 to $7.00 and set a "hold" rating for the company in a research note on Thursday, May 1st. Benchmark lowered their price objective on Enovix from $25.00 to $15.00 and set a "buy" rating for the company in a research report on Tuesday, April 15th. B. Riley dropped their price objective on Enovix from $17.00 to $12.00 and set a "buy" rating for the company in a report on Tuesday, April 29th. Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $30.00 target price on shares of Enovix in a research note on Thursday, February 20th. Finally, JPMorgan Chase & Co. lowered their price target on shares of Enovix from $10.00 to $9.00 and set an "overweight" rating for the company in a research report on Thursday, May 1st. Three research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $17.27.

Enovix Profile

Enovix Corporation designs develops and manufactures silicon-anode lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.

Want to see what other hedge funds are holding ENVX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Enovix Co. (NASDAQ:ENVX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.